N/A
Completed N=53
Sedation During Muscle Biopsy in Patients With Duchenne Muscular Dystrophy
Source: ClinicalTrials.gov NCT01645098 ↗Enrolled (actual)
53
Serious AEs
0.0%
Results posted
Feb 2015
Primary outcomePrimary: Time to Sedation Score of 3-4 — 3.7; 2.8 minutes
Summary
This is an interventional study on Duchenne muscular dystrophy patients who will be receiving sedation for a muscle biopsy as part of another study.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Time to Sedation Score of 3-4 |
3.7; 2.8 | — |
| SECONDARY Heart Rate Change After Dexmedetomidine Loading Dose |
-13; -5 | — |
| SECONDARY Mean Arterial Pressure (MAP) Change After Dexmedetomidine Loading Dose |
9; 5 | — |
| SECONDARY Oxygen Saturation Change After Dexmedetomidine Loading Dose |
-0.3; 0.4 | — |
| SECONDARY EtCO2 Change After Dexmedetomidine Loading Dose |
1; 2 | — |
Eligibility Criteria
Inclusion Criteria
- Patients undergoing a muscle biopsy for IRB11-00203.
Data sourced from ClinicalTrials.gov (NCT01645098). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.